Oncology Pharma ONPH Stock
Oncology Pharma Price Chart
Oncology Pharma ONPH Financial and Trading Overview
| Oncology Pharma stock price | 0.0000 USD |
| Previous Close | 0.7 USD |
| Open | 0.66 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.53 - 0.69 USD |
| 52 Week Range | 0.13 - 1.79 USD |
| Volume | 384.59K USD |
| Avg. Volume | 128.77K USD |
| Market Cap | 651.91K USD |
| Beta (5Y Monthly) | -0.16338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ONPH Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 63.82485 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Oncology Pharma Stock Price History
| Beta (5Y Monthly) | -0.16338 |
| 52-Week Change | -64.010% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.79 USD |
| 52 Week Low | 0.13 USD |
| 50-Day Moving Average | 0.19 USD |
| 200-Day Moving Average | 0.44 USD |
ONPH Share Statistics
| Avg. Volume (3 month) | 128.77K USD |
| Avg. Daily Volume (10-Days) | 333.33K USD |
| Shares Outstanding | 1.16M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.036% |
| Shares Short | 0 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2013 |
| Most Recent Quarter (mrq) | December 31, 2011 |
| Next Fiscal Year End | March 31, 2014 |
Profitability
| Profit Margin | 1821.37% |
| Operating Margin (ttm) | -141.65% |
| Gross Margin | 100.00% |
| EBITDA Margin | -84.68% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 10.21K USD |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 10.21K USD |
| EBITDA | -8650 USD |
| Net Income Avi to Common (ttm) | -15269 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.21K USD |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 788.53K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.878 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.06K USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Oncology Pharma
| Country | United States |
| State | CA |
| City | San Francisco |
| Address | 1 Sansome Street |
| ZIP | 94104 |
| Phone | 415-869-1036 |
| Website | https://www.oncology-pharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Q&A For Oncology Pharma Stock
What is a current ONPH stock price?
Oncology Pharma ONPH stock price today per share is 0.0000 USD.
How to purchase Oncology Pharma stock?
You can buy ONPH shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncology Pharma?
The stock symbol or ticker of Oncology Pharma is ONPH.
Which industry does the Oncology Pharma company belong to?
The Oncology Pharma industry is Biotechnology.
How many shares does Oncology Pharma have in circulation?
The max supply of Oncology Pharma shares is 0.
What is Oncology Pharma Price to Earnings Ratio (PE Ratio)?
Oncology Pharma PE Ratio is now.
What was Oncology Pharma earnings per share over the trailing 12 months (TTM)?
Oncology Pharma EPS is 0 USD over the trailing 12 months.
Which sector does the Oncology Pharma company belong to?
The Oncology Pharma sector is Healthcare.